Antiviral and immunomodulatory effects of polyphenols on macrophages infected with dengue virus serotypes 2 and 3 enhanced or not with antibodies

References

• Bhatt S, Gething PW, Brady OJ, et al. The global distribution and burden of dengue. Nature. 2013;496(7446):504–507. doi:10.1038/nature1206023563266
   PubMed Web of Science ®Google Scholar
• Gubler DJ. The economic burden of dengue. Am J Trop Med Hyg. 2012;86(5):743–744. doi:10.4269/ajtmh.2012.12-015722556068
   PubMed Web of Science ®Google Scholar
• Shepard DS, Undurraga EA, Halasa YA, Stanaway JD. The global economic burden of dengue: a systematic analysis. Lancet Infect Dis. 2016;16(8):935–941. doi:10.1016/S1473-3099(16)00146-827091092
   PubMed Web of Science ®Google Scholar
• Zubieta-Zavala A, Salinas-Escudero G, Ramírez-Chávez A, et al. Calculation of the average cost per case of dengue fever in Mexico using a micro-costing approach. PLoS Negl Trop Dis. 2016;10(8):e0004897. doi:10.1371/journal.pntd.000489727501146
   PubMed Web of Science ®Google Scholar
• World Health Organization. Dengue guidelines for diagnosis, treatment, prevention and control - New Edition; 2009 Available from: www.who.int/neglected_diseases/en. Accessed 11, 2018.
   Google Scholar
• Pan American Health Organization. Dengue Guidelines for Patient Care in the Region of the Americas. Washington, DC: Segunda; 2016 Available from: http://iris.paho.org/xmlui/bitstream/handle/123456789/31207/9789275118900-eng.pdf?sequence=1&isAllowed=y
   Google Scholar
• Martina BEE, Koraka P, Osterhaus ADME. Dengue virus pathogenesis: an integrated view. Clin Microbiol Rev. 2009;22(4):564–581. doi:10.1128/CMR.00035-0919822889
   PubMed Web of Science ®Google Scholar
• Green S, Rothman A. Immunopathological mechanisms in dengue and dengue hemorrhagic fever. Curr Opin Infect Dis. 2006;19(5):429–436. doi:10.1097/01.qco.0000244047.31135.fa16940865
   PubMed Web of Science ®Google Scholar
• Guzman MG, Alvarez M, Halstead SB. Secondary infection as a risk factor for dengue hemorrhagic fever/dengue shock syndrome: an historical perspective and role of antibody-dependent enhancement of infection. Arch Virol. 2013;158(7):1445–1459. doi:10.1007/s00705-013-1645-323471635
   PubMed Web of Science ®Google Scholar
• Sun P, Bauza K, Pal S, et al. Infection and activation of human peripheral blood monocytes by dengue viruses through the mechanism of antibody-dependent enhancement. Virology. 2011;421(2):245–252. doi:10.1016/j.virol.2011.08.02622033262
   PubMed Web of Science ®Google Scholar
• Katzelnick LC, Gresh L, Halloran ME, et al. Antibody-dependent enhancement of severe dengue disease in humans. Science (80-). 2017;358(6365):929–932. doi:10.1126/science.aan6836
   PubMed Web of Science ®Google Scholar
• Kuczera D, Assolini JP, Tomiotto-Pellissier F, Pavanelli WR, Silveira GF. Highlights for dengue immunopathogenesis: antibody-dependent enhancement, cytokine storm, and beyond. J Interferon Cytokine Res. 2018;38(2):69–80. doi:10.1089/jir.2017.003729443656
   PubMed Web of Science ®Google Scholar
• Puerta-Guardo H, Raya-Sandino A, González-Mariscal L, et al. The cytokine response of U937-derived macrophages infected through antibody-dependent enhancement of dengue virus disrupts cell apical-junction complexes and increases vascular permeability. J Virol. 2013;87(13):7486–7501. doi:10.1128/JVI.00085-1323616663
   PubMed Web of Science ®Google Scholar
• Bozza FA, Cruz OG, Zagne SM, et al. Multiplex cytokine profile from dengue patients: MIP-1beta and IFN-gamma as predictive factors for severity. BMC Infect Dis. 2008;8(1):86. doi:10.1186/1471-2334-8-8618578883
   PubMed Web of Science ®Google Scholar
• Butthep P, Chunhakan S, Yoksan S, Tangnararatchakit K, Chuansumrit A. Alteration of cytokines and chemokines during febrile episodes associated with endothelial cell damage and plasma leakage in dengue hemorrhagic fever. Pediatr Infect Dis J. 2012;31(12):232–238. doi:10.1097/INF.0b013e31826fd456
   Web of Science ®Google Scholar
• Green S, Vaughn DW, Kalayanarooj S, et al. Elevated plasma interleukin-10 levels in acute dengue correlate with disease severity. J Med Virol. 1999;59(3):329–334. Available from: http://www.ncbi.nlm.nih.gov/pubmed/10502265. Accessed, 2017.10502265
   PubMed Web of Science ®Google Scholar
• Flores-Mendoza LK, Estrada-Jiménez T, Sedeño-Monge V, et al. IL-10 and socs3 are predictive biomarkers of dengue hemorrhagic fever. Mediators Inflamm. 2017;2017:1–10. doi:10.1155/2017/5197592
   Web of Science ®Google Scholar
• Chen R-F, Yang KD, Lee I-K, et al. Augmented miR-150 expression associated with depressed SOCS1 expression involved in dengue haemorrhagic fever. J Infect. 2014;69(4):366–374. doi:10.1016/j.jinf.2014.05.01324907421
   PubMed Web of Science ®Google Scholar
• Rajapakse S, Rodrigo C, Rajapakse A. Treatment of dengue fever. Infect Drug Resist. 2012;5:103. doi:10.2147/IDR.S2261322870039
   PubMedGoogle Scholar
• Whitehorn J, Yacoub S, Anders KL, et al. Dengue therapeutics, chemoprophylaxis, and allied tools: state of the art and future directions. Rothman AL, ed. PLoS Negl Trop Dis. 2014;8(8):e3025. doi:10.1371/journal.pntd.000302525166493
   PubMed Web of Science ®Google Scholar
• Low JGH, Ooi EE, Vasudevan SG. Current status of dengue therapeutics research and development. J Infect Dis. 2017;215(suppl_2):S96–S102. doi:10.1093/infdis/jiw42328403438
   PubMed Web of Science ®Google Scholar
• Petrovska BB. Historical review of medicinal plants’ usage. Pharmacogn Rev. 2012;6(11):1–5. doi:10.4103/0973-7847.9584922654398
   PubMedGoogle Scholar
• Sanchez I, Gomez-Garibay F, Taboada J, Ruiz BH. Antiviral effect of flavonoids on the dengue virus. Phyther Res. 2000;14(2):89–92. doi:10.1002/(SICI)1099-1573(200003)14:2<89::AID-PTR569>3.0.CO;2-C
   PubMed Web of Science ®Google Scholar
• Whitby K, Pierson TC, Geiss B, et al. Castanospermine, a potent inhibitor of dengue virus infection in vitro and in vivo. J Virol. 2005;79(14):8698–8706. doi:10.1128/JVI.79.14.8698-8706.200515994763
   PubMed Web of Science ®Google Scholar
• Zandi K, Teoh B-T, Sam -S-S, Wong P-F, Mustafa M, AbuBakar S. Antiviral activity of four types of bioflavonoid against dengue virus type-2. Virol J. 2011;8(1):560. doi:10.1186/1743-422X-8-56022201648
   PubMed Web of Science ®Google Scholar
• Zandi K, Lim T-H, Rahim N-A, et al. Extract of scutellaria baicalensis inhibits dengue virus replication. BMC Complement Altern Med. 2013;13:91. doi:10.1186/1472-6882-13-9123627436
   PubMed Web of Science ®Google Scholar
• Lanciotti RS, Calisher CH, Gubler DJ, Chang GJ, Vorndam AV. Rapid detection and typing of dengue viruses from clinical samples by using reverse transcriptase-polymerase chain reaction. J Clin Microbiol. 1992;30(3):545–551. Available from: http://www.ncbi.nlm.nih.gov/pubmed/1372617. Accessed, 2018.1372617
   PubMed Web of Science ®Google Scholar
• Halstead SB. Dengue antibody-dependent enhancement: knowns and unknowns In: Antibodies for Infectious Diseases. Vol. 2 American Society of Microbiology;2014:249–271. doi:10.1128/microbiolspec.AID-0022-2014
   Google Scholar
• Ismail NA, Jusoh SA. Molecular docking and molecular dynamics simulation studies to predict flavonoid binding on the surface of DENV2 E protein. Interdiscip Sci Comput Life Sci. 2017;9(4):499–511. doi:10.1007/s12539-016-0157-8
   PubMed Web of Science ®Google Scholar
• Qamar MTU, Mumtaz A, Naseem R, et al. Molecular docking based screening of plant flavonoids as dengue NS1 inhibitors. Bioinformation. 2014;10(7):460–465. doi:10.6026/9732063001046025187688
   PubMedGoogle Scholar
• de Sousa LRF, Wu H, Nebo L, et al. Flavonoids as noncompetitive inhibitors of dengue virus NS2B-NS3 protease: inhibition kinetics and docking studies. Bioorg Med Chem. 2015;23(3):466–470. doi:10.1016/j.bmc.2014.12.01525564380
   PubMed Web of Science ®Google Scholar
• Senthilvel P, Lavanya P, Kumar KM, et al. Flavonoid from Carica papaya inhibits NS2B-NS3 protease and prevents dengue 2 viral assembly. Bioinformation. 2013;9(18):889–895. doi:10.6026/9732063000988924307765
   PubMedGoogle Scholar
• Igbe I, Shen X-F, Jiao W, et al. Dietary quercetin potentiates the antiproliferative effect of interferon-α in hepatocellular carcinoma cells through activation of JAK/STAT pathway signaling by inhibition of SHP2 phosphatase. Oncotarget. 2017;8(69):113734–113748. doi:10.18632/oncotarget.2255629371942
   PubMedGoogle Scholar
• Ashour J, Laurent-Rolle M, Shi P-Y, Garcia-Sastre A. NS5 of dengue virus mediates STAT2 binding and degradation. J Virol. 2009;83(11):5408–5418. doi:10.1128/JVI.02188-0819279106
   PubMed Web of Science ®Google Scholar
• Estrada-Jiménez T, Millán-Pérez Peña L, Flores-Mendoza L, et al. Upregulation of the suppressors of cytokine signaling 1 and 3 is associated with arrest of phosphorylated-STAT1 nuclear importation and reduced innate response in denguevirus-infected macrophages. Viral Immunol. 2016;29(2):95–104. doi:10.1089/vim.2014.013626709547
   PubMed Web of Science ®Google Scholar
• Ubol S, Phuklia W, Kalayanarooj S, Modhiran N. Mechanisms of immune evasion induced by a complex of dengue virus and preexisting enhancing antibodies. J Infect Dis. 2010;201(6):923–935. doi:10.1086/65101820158392
   PubMed Web of Science ®Google Scholar
• Palma-Ocampo HK, Flores-Alonso JC, Vallejo-Ruiz V, et al. Interferon lambda inhibits dengue virus replication in epithelial cells. Virol J. 2015;12:1. doi:10.1186/s12985-015-0383-425591713
   PubMed Web of Science ®Google Scholar
• Wiejak J, Dunlop J, Mackay SP, Yarwood SJ. Flavanoids induce expression of the suppressor of cytokine signalling 3 (SOCS3) gene and suppress IL-6-activated signal transducer and activator of transcription 3 (STAT3) activation in vascular endothelial cells. Biochem J. 2013;454(2):283–293. doi:10.1042/BJ2013048123782265
   PubMed Web of Science ®Google Scholar
• Kou Z, Quinn M, Chen H, et al. Monocytes, but not T or B cells, are the principal target cells for dengue virus (DV) infection among human peripheral blood mononuclear cells. J Med Virol. 2008;80(1):134–146. doi:10.1002/jmv.2105118041019
   PubMed Web of Science ®Google Scholar
• Chen S-T, Lin Y-L, Huang M-T, et al. CLEC5A is critical for dengue-virus-induced lethal disease. Nature. 2008;453(7195):672–676. doi:10.1038/nature0701318496526
   PubMed Web of Science ®Google Scholar
• Lo Y-L, Liou -G-G, Lyu J-H, Hsiao M, Hsu T-L, Wong C-H. Dengue virus infection is through a cooperative interaction between a mannose receptor and CLEC5A on macrophage as a multivalent hetero-complex. Pöhlmann S, ed. PLoS One. 2016;11(11):e0166474. doi:10.1371/journal.pone.016647427832191
   PubMed Web of Science ®Google Scholar
• Miller JL, de Wet BJM, de Wet BJM, et al. The mannose receptor mediates dengue virus infection of macrophages. PLoS Pathog. 2008;4(2):e17. doi:10.1371/journal.ppat.004001718266465
   PubMed Web of Science ®Google Scholar
• Tassaneetrithep B, Burgess TH, Granelli-Piperno A, et al. DC-SIGN (CD209) mediates dengue virus infection of human dendritic cells. J Exp Med. 2003;197(7):823–829. doi:10.1084/jem.2002184012682107
   PubMed Web of Science ®Google Scholar
• Lozach P-Y, Burleigh L, Staropoli I, et al. Dendritic cell-specific intercellular adhesion molecule 3-grabbing non-integrin (DC-SIGN)-mediated enhancement of dengue virus infection is independent of DC-SIGN internalization signals. J Biol Chem. 2005;280(25):23698–23708. doi:10.1074/jbc.M50433720015855154
   PubMed Web of Science ®Google Scholar
• Chan KR, Zhang SL-X, Tan HC, et al. Ligation of Fc gamma receptor IIB inhibits antibody-dependent enhancement of dengue virus infection. Proc Natl Acad Sci U S A. 2011;108(30):12479–12484. doi:10.1073/pnas.110656810821746897
   PubMed Web of Science ®Google Scholar
• Bournazos S, Wang TT, Dahan R, Maamary J, Ravetch JV. Signaling by antibodies: recent progress. Annu Rev Immunol. 2017;35(1):285–311. doi:10.1146/annurev-immunol-051116-05243328446061
   PubMed Web of Science ®Google Scholar
• Palma A, Jarrah AS, Tieri P, Cesareni G, Castiglione F. Gene regulatory network modeling of macrophage differentiation corroborates the continuum hypothesis of polarization states. Front Physiol. 2018;9:1659. doi:10.3389/fphys.2018.0165930546316
   PubMed Web of Science ®Google Scholar
• Vogelpoel LTC, Hansen IS, Rispens T, et al. Fc gamma receptor-TLR cross-talk elicits pro-inflammatory cytokine production by human M2 macrophages. Nat Commun. 2014;5(1):5444. doi:10.1038/ncomms644425392121
   PubMed Web of Science ®Google Scholar
• Hoesel B, Schmid JA. The complexity of NF-κB signaling in inflammation and cancer. Mol Cancer. 2013;12(1):86. doi:10.1186/1476-4598-12-8623915189
   PubMed Web of Science ®Google Scholar
• Sam -S-S, Teoh B-T, Chinna K, AbuBakar S. High producing tumor necrosis factor alpha gene alleles in protection against severe manifestations of dengue. Int J Med Sci. 2015;12(2):177–186. doi:10.7150/ijms.898825589894
   PubMed Web of Science ®Google Scholar
• Wan S-W, Yang Y-W, Chu Y-T, et al. Anti-dengue virus nonstructural protein 1 antibodies contribute to platelet phagocytosis by macrophages. Thromb Haemost. 2016;115(03):646–656. doi:10.1160/th15-06-049826632672
   PubMed Web of Science ®Google Scholar
• Lardo S, Wibisono D, Sulistyo B, Purnama Y. The effect of a unique propolis compound (PropoelixTM) on clinical outcomes in patients with dengue hemorrhagic fever. Infect Drug Resist. 2014;323. doi:10.2147/IDR.S7150525525372
   PubMed Web of Science ®Google Scholar
• Puerta-Guardo H, Glasner DR, Harris E. Dengue virus NS1 disrupts the endothelial glycocalyx, leading to hyperpermeability. Kuhn RJ, ed. PLoS Pathog. 2016;12(7):e1005738. doi:10.1371/journal.ppat.100573827416066
   PubMed Web of Science ®Google Scholar
• Alayli F, Scholle F. Dengue virus NS1 enhances viral replication and pro-inflammatory cytokine production in human dendritic cells. Virology. 2016;496:227–236. doi:10.1016/j.virol.2016.06.00827348054
   PubMed Web of Science ®Google Scholar
• Padilla-S L, Rodríguez A, Gonzales MM, Gallego-G JC, Castaño-O JC. Inhibitory effects of curcumin on dengue virus type 2-infected cells in vitro. Arch Virol. 2014;159(3):573–579. doi:10.1007/s00705-013-1849-624081825
   PubMed Web of Science ®Google Scholar
• Nagila A, Netsawang J, Suttitheptumrong A, et al. Inhibition of p38MAPK and CD137 signaling reduce dengue virus-induced TNF-α secretion and apoptosis. Virol J. 2013;10(1):105. doi:10.1186/1743-422X-10-10523557259
   PubMed Web of Science ®Google Scholar
• Sreekanth GP, Yenchitsomanus P, Limjindaporn T. Role of mitogen-activated protein kinase signaling in the pathogenesis of dengue virus infection. Cell Signal. 2018;48:64–68. doi:10.1016/j.cellsig.2018.05.00229753850
   PubMed Web of Science ®Google Scholar
• Endale M, Park S-C, Kim S, et al. Quercetin disrupts tyrosine-phosphorylated phosphatidylinositol 3-kinase and myeloid differentiation factor-88 association, and inhibits MAPK/AP-1 and IKK/NF-κB-induced inflammatory mediators production in RAW 264.7 cells. Immunobiology. 2013;218(12):1452–1467. doi:10.1016/j.imbio.2013.04.01923735482
   PubMed Web of Science ®Google Scholar
• Wright B, Watson KA, McGuffin LJ, Lovegrove JA, Gibbins JM. GRID and docking analyses reveal a molecular basis for flavonoid inhibition of Src family kinase activity. J Nutr Biochem. 2015;26(11):1156–1165. doi:10.1016/j.jnutbio.2015.05.00426140983
   PubMed Web of Science ®Google Scholar
• Chi H, Barry SP, Roth RJ, et al. Dynamic regulation of pro- and anti-inflammatory cytokines by MAPK phosphatase 1 (MKP-1) in innate immune responses. Proc Natl Acad Sci. 2006;103(7):2274–2279. doi:10.1073/pnas.051096510316461893
   PubMed Web of Science ®Google Scholar
• Donnelly RP, Freeman SL, Hayes MP. Inhibition of IL-10 expression by IFN-gamma up-regulates transcription of TNF-alpha in human monocytes. J Immunol. 1995;155(3):1420–1427. Available from: http://www.ncbi.nlm.nih.gov/pubmed/7636207. Accessed, 2019.7636207
   PubMed Web of Science ®Google Scholar
• Bogdan C, Paik J, Vodovotz Y, Nathan C. Contrasting mechanisms for suppression of macrophage cytokine release by transforming growth factor-beta and interleukin-10. J Biol Chem. 1992;267(32):23301–23308. Available from: http://www.ncbi.nlm.nih.gov/pubmed/1429677. Accessed, 2019.1429677
   PubMed Web of Science ®Google Scholar
• Kim JH, Kim MY, Kim JH, Cho JY. Fisetin suppresses macrophage-mediated inflammatory responses by blockade of Src and Syk. Biomol Ther. 2015;23(5):414–420. doi:10.4062/biomolther.2015.036
   PubMed Web of Science ®Google Scholar
• Terao J. Factors modulating bioavailability of quercetin-related flavonoids and the consequences of their vascular function. Biochem Pharmacol. 2017;139:15–23. doi:10.1016/j.bcp.2017.03.02128377278
   PubMed Web of Science ®Google Scholar
• Manach C, Donovan JL. Pharmacokinetics and metabolism of dietary flavonoids in humans. Free Radic Res. 2004;38(8):771–785. http://www.ncbi.nlm.nih.gov/pubmed/15493450. Accessed, 2019.15493450
   PubMed Web of Science ®Google Scholar